These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2421479)
21. Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus. Sil BK; Dunster LM; Ledger TN; Wills MR; Minor PD; Barrett AD J Virol; 1992 Jul; 66(7):4265-70. PubMed ID: 1376368 [TBL] [Abstract][Full Text] [Related]
22. Immunoblotting reveals differences in the accumulation of envelope protein by wild-type and vaccine strains of yellow fever virus. Cane PA; Gould EA J Gen Virol; 1989 Mar; 70 ( Pt 3)():557-64. PubMed ID: 2732701 [TBL] [Abstract][Full Text] [Related]
23. Epitope analysis of the envelope and non-structural glycoproteins of Murray Valley encephalitis virus. Hall RA; Kay BH; Burgess GW; Clancy P; Fanning ID J Gen Virol; 1990 Dec; 71 ( Pt 12)():2923-30. PubMed ID: 1703213 [TBL] [Abstract][Full Text] [Related]
24. Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice. van der Most RG; Harrington LE; Giuggio V; Mahar PL; Ahmed R Virology; 2002 Apr; 296(1):117-24. PubMed ID: 12036323 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Hahn CS; Dalrymple JM; Strauss JH; Rice CM Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2019-23. PubMed ID: 3470774 [TBL] [Abstract][Full Text] [Related]
26. 17D yellow fever vaccine virus envelope protein expressed by recombinant baculovirus is antigenically indistinguishable from authentic viral protein. Shiu SY; Morikawa S; Buckley A; Higgs S; Karunakarannair V; Blachere C; Gould EA J Gen Virol; 1991 Jun; 72 ( Pt 6)():1451-4. PubMed ID: 1710651 [TBL] [Abstract][Full Text] [Related]
27. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants. Daffis S; Kontermann RE; Korimbocus J; Zeller H; Klenk HD; Ter Meulen J Virology; 2005 Jul; 337(2):262-72. PubMed ID: 15919103 [TBL] [Abstract][Full Text] [Related]
28. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice. Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294 [TBL] [Abstract][Full Text] [Related]
29. Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced world-wide. Monath TP; Kinney RM; Schlesinger JJ; Brandriss MW; Brès P J Gen Virol; 1983 Mar; 64 Pt 3():627-37. PubMed ID: 6298349 [TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies against avian reticuloendotheliosis virus: identification of strain-specific and strain-common epitopes. Cui ZZ; Lee LF; Silva RF; Witter RL J Immunol; 1986 Jun; 136(11):4237-42. PubMed ID: 2422277 [TBL] [Abstract][Full Text] [Related]
31. Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes. Ryman KD; Ledger TN; Weir RC; Schlesinger JJ; Barrett AD J Gen Virol; 1997 Jun; 78 ( Pt 6)():1353-6. PubMed ID: 9191929 [TBL] [Abstract][Full Text] [Related]
32. Structural and Nonstructural Genes Contribute to the Genetic Diversity of RNA Viruses. Collins ND; Beck AS; Widen SG; Wood TG; Higgs S; Barrett ADT mBio; 2018 Oct; 9(5):. PubMed ID: 30377281 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine. Wang E; Ryman KD; Jennings AD; Wood DJ; Taffs F; Minor PD; Sanders PG; Barrett AD J Gen Virol; 1995 Nov; 76 ( Pt 11)():2749-55. PubMed ID: 7595382 [TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Roehrig JT; Bolin RA; Kelly RG Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950 [TBL] [Abstract][Full Text] [Related]
35. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies. Buckley A; Gould EA J Gen Virol; 1985 Dec; 66 ( Pt 12)():2523-31. PubMed ID: 2999305 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it. Jennings AD; Whitby JE; Minor PD; Barrett AD Virology; 1993 Feb; 192(2):692-5. PubMed ID: 8421909 [TBL] [Abstract][Full Text] [Related]
37. A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Heinz FX; Berger R; Tuma W; Kunz C Virology; 1983 Apr; 126(2):525-37. PubMed ID: 6190308 [TBL] [Abstract][Full Text] [Related]
38. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus. Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154 [TBL] [Abstract][Full Text] [Related]
39. Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH. Guirakhoo F; Heinz FX; Kunz C Virology; 1989 Mar; 169(1):90-9. PubMed ID: 2466373 [TBL] [Abstract][Full Text] [Related]
40. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. Gould EA; Buckley A; Barrett AD; Cammack N J Gen Virol; 1986 Mar; 67 ( Pt 3)():591-5. PubMed ID: 3950582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]